Skip to content

Study · Animal study (in vivo) · 1998

1 result

A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thogersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH

Journal of medicinal chemistry1 Sept 1998Cited by 20 (Europe PMC)

PMID9733495 (opens in a new tab)DOI10.1021/jm9801962 (opens in a new tab)PepBankPUB-09733495
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Activity measurement

    After oral administration of 2.7 mg/kg, ipamorelin increased basal GH level by more than 10-fold.

    In plain wordsIn animals, oral ipamorelin raised baseline growth hormone more than 10-fold.

    Peptide
    Ipamorelin
    Outcome
    IncreaseBasal GH level after oral dosing
    Study

    n: not reported in source

    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2.7 mg/kg · oralAs given in this study.

    Source sentences

    Summary
    NNC 26-0235 and ipamorelin were able to increase basal GH level by more than 10-fold after oral administration of a dose of 1.8 and 2.7 mg/kg, respectively.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 22 to 45Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 24 times, first on 13 Oct 2026, 21:43 UTC. The status did not change between them.

    Study results updated

  2. Version 21

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Versions 3 to 20

    13 Oct 2026, 14:22 UTC

    The same notice was added 18 times, first on 9 Oct 2026, 18:17 UTC. The status did not change between them.

    Study results updated

  4. Version 2

    9 Oct 2026, 03:13 UTC

    Study data updated · source update from Europe PMC

  5. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.